SQI Diagnostics

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Our mission is to continue to develop proprietary technologies and products for advanced multiplexed diagnostics to enable healthcare professionals to cost-effectively diagnose, monitor and manage complex diseases earlier and more accurately than conventional methods.

Our vision is to be the premier provider of comprehensive, advanced, and high-quality diagnostics services and products in the healthcare industry.

SQI Diagnostics has won several awards, including recognition as one of Canada's Top 10 Most Admired Corporate Cultures in 2016, 2017, and 2018; Deloitte's Technology Fast 50 for 2018; and the Markham Board of Trade's Business Excellence Award for Fastest Growing Business in 2018.